{"id":"W2009085459","doi":"10.1517/13543780903336050","title":"Antivascular agents for non-small-cell lung cancer: current status and future directions","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bevacizumab; Medicine; Oncology; Targeted therapy; Lung cancer; Clinical trial; Internal medicine; Vascular endothelial growth factor; Chemotherapy; Monoclonal antibody; Cancer; Intensive care medicine; VEGF receptors; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001133884,0.0004378407,0.0005468751,0.000107695,0.0002405991,0.00004529313,0.0001764567,0.0003383612,0.00002286874],"category_scores_gemma":[0.00001795645,0.0003801451,0.0004760998,0.0001387409,0.00007999472,0.000005888939,0.00006354951,0.0001535294,0.000003627593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009955793,"about_ca_system_score_gemma":0.0006729005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000019322,"about_ca_topic_score_gemma":0.00000170237,"domain_scores_codex":[0.9982912,0.00008392687,0.0003872719,0.0007038817,0.0002138804,0.0003198491],"domain_scores_gemma":[0.9990687,0.0000340935,0.0002484977,0.0003028958,0.0001204123,0.0002253985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001029087,0.00009107588,0.00003459326,0.001772758,0.0001930807,1.550632e-7,0.0001193329,0.000006602014,0.00003973893,0.0003845174,0.06877863,0.9285692],"study_design_scores_gemma":[0.0003622063,0.00007286276,0.00006641084,0.002054203,0.00005579372,0.000001791702,0.00001877106,0.00003198786,0.0001834407,0.00002306962,0.9966926,0.0004368384],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007857347,0.9961362,0.0001165777,0.0002193592,0.001907935,0.0009635777,0.0004133807,0.000015486,0.0001488731],"genre_scores_gemma":[0.000005436737,0.9892409,0.0005576722,0.00046692,0.00508075,0.001049192,0.003271062,0.00006290938,0.0002651236],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9281324,"threshold_uncertainty_score":0.9998651,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03724310527637133,"score_gpt":0.3574895587803171,"score_spread":0.3202464535039458,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}